FDA inspection

Styrax Pharma Private Limited: FDA inspection ending Nov 9, 2018

FDA inspection 1071264 · Voluntary Action Indicated (VAI) · Visakhapatnam

Key facts

Inspection ID 1071264
Firm Styrax Pharma Private Limited
FEI number 3014406503
Address Plot No. 27b, Jnpc Parwada
City Visakhapatnam
Fiscal year 2019
Inspection end date Nov 9, 2018
Classification Voluntary Action Indicated (VAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections